SCHEMBL3058338

SCHEMBL3058338

Cc1nccc2[nH]c(=S)ccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 7/20 1.00
PDE3A Q14432 7/20 1.00
ALDH1A1 P00352 6/20 0.43
KDM4E B2RXH2 4/20 0.43
HPGD P15428 4/20 0.43
HSD17B10 Q99714 4/20 0.43
MAOA P21397 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2D6 P10635 2/20 0.43
GABRP O00591 1/20 0.43
GABRD O14764 1/20 0.43
GABRA1 P14867 1/20 0.43
TSHR P16473 1/20 0.43
GABRB1 P18505 1/20 0.43
GABRG2 P18507 1/20 0.43
NFKB1 P19838 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Medorinone SCHEMBL121782 0.77 PDE3B (1.00) PDE3BPDE3AALDH1A1KDM4EHPGD
SCHEMBL4550230 0.74 PDE3B (0.58) PDE3BPDE3AALDH1A1KDM4EHPGD
SCHEMBL17531158 0.72 PDE3B (0.56) PDE3BPDE3AALDH1A1KDM4EHPGD
SCHEMBL10809624 0.68 PDE3B (0.60) PDE3BPDE3AALDH1A1KDM4EKMT2A
SCHEMBL10812608 0.68 PDE3B (0.60) PDE3BPDE3AALDH1A1KDM4EHPGD
SCHEMBL19153110 0.68 PDE3B (0.61) PDE3BPDE3AALDH1A1KDM4EHPGD
SCHEMBL23511564 0.67 PDE3B (0.50) PDE3BPDE3AALDH1A1KDM4EHPGD
SCHEMBL26144292 0.67 PDE3B (0.50) PDE3BPDE3AALDH1A1KDM4EHPGD
SCHEMBL9329888 0.67 PDE3B (0.55) PDE3BPDE3AALDH1A1KDM4EHPGD
SCHEMBL12266516 0.66 CYP2A6 (0.56) PDE3BPDE3AALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399447-B2 Metal triangulo compound and methods of using the same NATIONAL UNIVERSITY OF SINGAPORE (SG) 2013-03-19 US disclosed
US-20100209431-A1 METAL TRIANGULO COMPOUND AND METHODS OF USING THE SAME NATIONAL UNIVERSITY OF SINGAPORE 2010-08-19 US disclosed
EP-2147005-A1 METAL TRIANGULO COMPOUND AND METHODS OF USING THE SAME National University of Singapore (SG) 2010-01-27 EP disclosed
WO-2008127197-A1 METAL TRIANGULO COMPOUND AND METHODS OF USING THE SAME NATIONAL UNIVERSITY OF SINGAPORE (SG) 2008-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100209431-A1 METAL TRIANGULO COMPOUND AND METHODS OF USING THE SAME CASP3, BAX, CASP7 PDE3B 4835/4885PDE3A 4868/4885ALDH1A1 1447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.